A new study may help shed light on the diversity of dementias linked to tau protein aggregation.
Researchers report a new DNA vaccine prompts an immune response to proteins associated with Alzheimer's disease.
Eating late, or at inappropriate times might have a significant impact on both weight and normal sleep-wake patterns, a new study published in Cell Metabolism reports.
A new study reveals mice with higher levels of BMAL1 in their muscles were able to recover from sleep deprivation more quickly than those with the protein removed.
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.
According to a Cell Reports study, mice with abnormal eating schedules are more likely to develop skin cancer cells. Researchers report abnormal eating times disrupt the skin's circadian cycle and weakens the potency of an enzyme that protects against UV rays.
A new Science study sheds light on how the gut microbiota interacts with circadian rhythm to impact metabolism. Researchers say the finding could help explain why those who work night shifts have higher rates of metabolic diseases.
UT Southwestern researchers discover a gene implicated in circadian rhythm may also play a vital role in regulating genes important for our brain evolution.
A detailed 3D structure of nicotinic acetylcholine receptors could help pave the way to developing new treatments for nicotine addiction, researchers report.
A new study sheds light on the biochemistry of sleep need in the brain.
Researchers have made a surprise discovery that could help provide treatment options for a range of conditions from Parkinson's disease to depression. Researching how to transform supportive brain cells into neurons, the scientists unexpectedly transformed mature inhibitory striatal neurons into dopamine producing neurons.
A new DNA vaccine tested in mice significantly reduces tau and amyloid beta, two proteins implicated in Alzheimer's disease. The findings, researchers say, may pave the way for clinical trials in humans with the neurodegenerative disease.
